Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study

Fig. 2

HRs and 95% CI of HHF according to DKD/MAFLD phenotype. DKD: diabetic kidney disease; HHF: hospitalization for heart failure; MAFLD: metabolic dysfunction–associated fatty liver disease; PU: proteinuria. no-DKD: normal eGFR (eGFR ≥ 60) with negative PU; PU+DKD: normal eGFR with positive PU; PU−DKD: reduced eGFR (eGFR < 60) with negative PU. HRs were adjusted for age, sex, smoking, alcohol, exercise, hypertension, dyslipidemia, atrial fibrillation, ischemic heart disease, fasting plasma glucose, diabetes duration, hemoglobin levels, and insulin usage

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us